Jan 22, 2022

• Featuring an interview with Dr Evan Yu, including the following topics:
• Efficacy, safety and optimal use of 177Lu-PSMA-617 (0:00)
• Current role of immuno-oncology (IO) in the management of metastatic prostate cancer (mCRPC) (18:13)
• Combining IO with other targeted agents for patients with mCRPC (24:50)

CME information...

Jan 22, 2022

Featuring perspectives from Drs Alice Mims, Alexander Perl, Richard Stone and Geoffrey Uy, moderated by Dr Harry Paul Erba, including the following topics:

• Introduction (0:00)
• Front-Line Treatment for Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Therapy (4:15)
• Induction...

Jan 21, 2022

Featuring perspectives from Dr Brian Hill, including the following topics: 

• Introduction: ASH 2021 — Diffuse Large B-Cell Lymphoma (DLBCL) (0:00)
• Case: A man in his late 70s with relapsed/refractory DLBCL — Syed F Zafar, MD (16:55)
• Case: A man in his late 60s with advanced DLBCL — Shaachi Gupta, MD,...

Jan 19, 2022

Featuring perspectives from Drs Nitin Jain, Anthony Mato, John Pagel and Jennifer Woyach, moderated by Dr John Allan, including the following topics:

• Introduction (0:00)
• Front-Line Treatment for Patients with Chronic Lymphocytic Leukemia (CLL) (5:29)
• Novel Strategies Combining Bruton Tyrosine Kinase (BTK) and Bcl-2...

Jan 18, 2022

Featuring perspectives from Dr Jason Luke, including the following topics: 

• Introduction (0:00)
• DREAMseq Phase III Study (3:03)
• Case: A woman in her mid-50s with metastatic melanoma and a BRAF V600K mutation — Evan J Lipson, MD (18:08)
• Case: A man in his mid-60s with metastatic melanoma and a BRAF V600E mutation —...